Does the Use of Rocuronium-Sugammadex Instead of Succinylcholine in Electroconvulsive Therapy Affect Seizure Duration?

키워드

참고문헌 (35)

1. Liu CC, "Electroconvulsive therapy under general anesthesia with cisatracurium, laryngeal mask airways, and bispectral index", J ECT, 32, pp.17~19 (2016)
2. Joo SW, "Effects of stimulus parameters on motor seizure duration in electroconvulsive therapy", Neuropsychiatr Dis Treat, 13, pp.1427~1434 (2017)
3. Luccarelli J, "Changes in seizure duration during acute course electroconvulsive therapy", Brain Stimul, 14, pp.941~946 (2021)
4. Ding Z, "Anesthesia for electroconvulsive therapy", Anesth Analg, 94, pp.1351~1364 (2002)
5. Mirzakhani H, "Neuromuscular blocking agents for electroconvulsive therapy: a systematic review", Acta Anaesthesiol Scand, 56, pp.3~16 (2012)
6. Bohringer C, "Is there still a role for succinylcholine in contemporary clinical practice?", Transl Perioper Pain Med, 6, pp.129~135 (2019)
7. Booij LH, "Is succinylcholine appropriate or obsolete in the intensive care unit?", Crit Care, 5, pp.245~246 (2001)
8. Hager HH, "Succinylcholine chloride" (2022), StatPearls
9. Naguib M, "The use of low-dose rocuronium to facilitate laryngeal mask airway insertion", Middle East J Anaesthesiol, 16, pp.41~54 (2001)
10. Sugammadex for the reversal of neuromuscular blockade in surgical patients: a review of clinical effectiveness and costeffectiveness, "Brett K", Canadian Agency for Drugs and Technologies in Health, ~ (2019)
11. Postaci A, "Rocuronium-sugammadex decreases the severity of post-electroconvulsive therapy agitation", J ECT, 29, pp.e2~e3 (2013)
12. Casas Reza P, "Rocuronium-sugammadex for electroconvulsive therapy management in neuroleptic malignant syndrome: a case report", Rev Esp Anestesiol Reanim, 64, pp.105~107 (2017)
13. Saricicek V, "Does rocuronium-sugammadex reduce myalgia and headache after electroconvulsive therapy in patients with major depression?", J ECT, 30, pp.30~34 (2014)
14. Kadoi Y, "Comparison of recovery times from rocuronium-induced muscle relaxation after reversal with three different doses of sugammadex and succinylcholine during electroconvulsive therapy", J Anesth, 25, pp.855~859 (2011)
15. Koksal E, "Comparing the effects of rocuronium-sugammadex and succinylcholine on recovery during electroconvulsive therapy", Anadolu Psikiyatri Derg, 16, pp.198~204 (2015)
16. Hoshi H, "Use of rocuronium-sugammadex, an alternative to succinylcholine, as a muscle relaxant during electroconvulsive therapy", J Anesth, 25, pp.286~290 (2011)
17. Takazawa T, "Comparison between succinylcholine and rocuronium as neuromuscular blocking agents for electroconvulsive therapy in a patient with pseudocholinesterase deficiency", JA Clin Rep, 1, pp.7~ (2015)
18. Fuchs-Buder T, "Is sugammadex economically viable for routine use", Curr Opin Anaesthesiol, 25, pp.217~220 (2012)
19. Wang CC, "The clonic phase of seizures in patients treated with electroconvulsive therapy is related to age and stimulus intensity", Front Psychiatry, 4, pp.166~ (2013)
20. Singh PM, "Evaluation of etomidate for seizure duration in electroconvulsive therapy: a systematic review and meta-analysis", J ECT, 31, pp.213~225 (2015)
21. Puffer CC, "A 20 year practice review of electroconvulsive therapy for adolescents", J Child Adolesc Psychopharmacol, 26, pp.632~636 (2016)
22. Canbek O, "Report on 3years’ experience in electroconvulsive therapy in bakirkoy research and training hospital for psychiatric and neurological diseases: 2008-2010", J ECT, 29, pp.51~57 (2013)
23. American Psychiatric Association, "The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging: a task force report" (2001), American Psychiatric Association
24. Royal College of Psychiatrists, "The ECT handbook: the third report of the Royal College of Psychiatrists’ special committee on ECT" (2005), Royal College of Psychiatrists
25. Abd El-Rahman AM, "Comparison of three different doses sugammadex based on ideal body weight for reversal of moderate rocuronium-induced neuromuscular blockade in laparoscopic bariatric surgery", Minerva Anestesiol, 83, pp.138~144 (2017)
26. Sorgenfrei IF, "Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study", Anesthesiology, 104, pp.667~674 (2006)
27. Nordenskjöld A, "Predictors of the shortterm responder rate of electroconvulsive therapy in depressive disorders--a population based study", BMC Psychiatry, 12, pp.115~ (2012)
28. Pühringer FK, "Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessorblinded, phase II trial", Anesthesiology, 109, pp.188~197 (2008)
29. Meistelman C, "Rocuronium (ORG 9426) neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans", Can J Anaesth, 39, pp.665~669 (1992)
30. Barclay K, "Low-dose rocuronium improves conditions for tracheal intubation after induction of anaesthesia with propofol and alfentanil", Br J Anaesth, 78, pp.92~94 (1997)
31. Turkkal DC, "A cross-over, post-electroconvulsive therapy comparison of clinical recovery from rocuronium versus succinylcholine", J Clin Anesth, 20, pp.589~593 (2008)
32. Ghezel-Ahmadi V, "Comparing patient satisfaction and intubating conditions using succinylcholine or low-dose rocuronium for rigid bronchoscopy: a randomized study", Thorac Cardiovasc Surg, 63, pp.526~532 (2015)
33. Atagun Mİ, "Serum nitric oxide levels are depleted in depressed patients treated with electroconvulsive therapy", Indian J Psychiatry, 63, pp.456~461 (2021)
34. Mirzakhani H, "Minimum effective doses of succinylcholine and rocuronium during electroconvulsive therapy: a prospective, randomized, crossover trial", Anesth Analg, 123, pp.587~596 (2016)
35. Saito S, "Anesthesia management for electroconvulsive therapy: hemodynamic and respiratory management", J Anesth, 19, pp.142~149 (2005)

관련 논문AI추천